JP5964956B2 - 胎児の組織からの親細胞バンクの調製 - Google Patents

胎児の組織からの親細胞バンクの調製 Download PDF

Info

Publication number
JP5964956B2
JP5964956B2 JP2014519671A JP2014519671A JP5964956B2 JP 5964956 B2 JP5964956 B2 JP 5964956B2 JP 2014519671 A JP2014519671 A JP 2014519671A JP 2014519671 A JP2014519671 A JP 2014519671A JP 5964956 B2 JP5964956 B2 JP 5964956B2
Authority
JP
Japan
Prior art keywords
fetal
cells
tissue
skin
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014519671A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014520546A (ja
JP2014520546A5 (https=
Inventor
リー アン ローラン−アップルゲート
リー アン ローラン−アップルゲート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Hospitalier Universitaire Vaudois CHUV
Original Assignee
Centre Hospitalier Universitaire Vaudois CHUV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Hospitalier Universitaire Vaudois CHUV filed Critical Centre Hospitalier Universitaire Vaudois CHUV
Publication of JP2014520546A publication Critical patent/JP2014520546A/ja
Publication of JP2014520546A5 publication Critical patent/JP2014520546A5/ja
Application granted granted Critical
Publication of JP5964956B2 publication Critical patent/JP5964956B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/066—Tenocytes; Tendons, Ligaments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Rehabilitation Therapy (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
JP2014519671A 2011-07-11 2012-07-10 胎児の組織からの親細胞バンクの調製 Active JP5964956B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11173452.1 2011-07-11
EP11173452A EP2546335A1 (en) 2011-07-11 2011-07-11 Foetal epiphyseal chondrocyte (FEC) parental cell bank
PCT/IB2012/053512 WO2013008174A1 (en) 2011-07-11 2012-07-10 Preparation of parental cell bank from foetal tissue

Publications (3)

Publication Number Publication Date
JP2014520546A JP2014520546A (ja) 2014-08-25
JP2014520546A5 JP2014520546A5 (https=) 2016-05-12
JP5964956B2 true JP5964956B2 (ja) 2016-08-03

Family

ID=46717923

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014519671A Active JP5964956B2 (ja) 2011-07-11 2012-07-10 胎児の組織からの親細胞バンクの調製

Country Status (7)

Country Link
US (2) US8986678B2 (https=)
EP (2) EP2546335A1 (https=)
JP (1) JP5964956B2 (https=)
CN (1) CN103874763A (https=)
ES (1) ES2654292T3 (https=)
PL (1) PL2732030T3 (https=)
WO (1) WO2013008174A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2546335A1 (en) 2011-07-11 2013-01-16 Centre Hospitalier Universitaire Vaudois (CHUV) Foetal epiphyseal chondrocyte (FEC) parental cell bank
CN104789524A (zh) * 2015-04-30 2015-07-22 四川大学 骨质疏松大鼠原代成骨细胞分离培养方法及应用
KR101836475B1 (ko) * 2016-08-02 2018-03-08 아주대학교산학협력단 연골 재생용 조성물 및 이의 제조방법
FR3100652A1 (fr) 2019-09-06 2021-03-12 Schneider Electric Industries Sas Transformateur multi-secondaire

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008128304A1 (en) * 2007-04-24 2008-10-30 The University Of Western Australia Tenocyte containing bioscaffolds and treatment using the same
FR2921668A1 (fr) * 2007-09-28 2009-04-03 Univ Bretagne Occidentale Etab Nouvelles compositions lipophiles et leurs utilisations.
EP2546335A1 (en) 2011-07-11 2013-01-16 Centre Hospitalier Universitaire Vaudois (CHUV) Foetal epiphyseal chondrocyte (FEC) parental cell bank

Also Published As

Publication number Publication date
JP2014520546A (ja) 2014-08-25
CN103874763A (zh) 2014-06-18
EP2732030B1 (en) 2017-09-27
US9434923B2 (en) 2016-09-06
PL2732030T3 (pl) 2018-07-31
ES2654292T3 (es) 2018-02-13
US20150152388A1 (en) 2015-06-04
EP2546335A1 (en) 2013-01-16
WO2013008174A1 (en) 2013-01-17
EP2732030A1 (en) 2014-05-21
HK1198179A1 (en) 2015-03-13
US20140193377A1 (en) 2014-07-10
US8986678B2 (en) 2015-03-24

Similar Documents

Publication Publication Date Title
Ringe et al. Stem cells for regenerative medicine: advances in the engineering of tissues and organs
Arinzeh et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect
Shen et al. Implications of adipose-derived stromal cells in a 3D culture system for osteogenic differentiation: an in vitro and in vivo investigation
Toratani et al. Scaffold-free tissue-engineered allogenic adipose-derived stem cells promote meniscus healing
KR102479530B1 (ko) 인간 유도 만능 줄기세포로부터 연골세포의 펠렛을 제조하는 방법 및 이의 용도
KR101697141B1 (ko) 연골 재생용 세포 치료제
JP2003510108A (ja) 生物学的関節構造体
Danišovič et al. Comparative analysis of mesenchymal stromal cells from different tissue sources in respect to articular cartilage tissue engineering
CN106459908A (zh) 来源于纯滋养层的干细胞及包含其的细胞治疗剂
JP2011041472A (ja) 細胞混合物からなる細胞移植治療用スフェロイド及びその作製方法
JP5964956B2 (ja) 胎児の組織からの親細胞バンクの調製
JP2022501118A (ja) 脂肪由来幹細胞およびゼラチンを含む生体材料ならびにその製造方法
Nauta et al. Adult stem cells in small animal wound healing models
CN102002479A (zh) 一种脐带血间充质干细胞及其制备方法和用途
Schwarz et al. Characterization of adipose-derived equine and canine mesenchymal stem cells after incubation in agarose-hydrogel
TWI622649B (zh) 從胎兒組織製備親代細胞庫
KR20130102506A (ko) 성숙 낭성 기형종 유래 세포 및 조직의 용도
RU2800991C2 (ru) Способ биофабрикации трансплантата в виде клеточных сфероидов для регенеративных технологий восстановления хряща субъекта на основе надхрящницы собственного реберного хряща субъекта и мультипотентных мезенхимальных стромальных клеток костного мозга этого же субъекта
HK1198179B (en) Preparation of parental cell bank from foetal tissue
Ali Stemness and osteogenic differentiation of induced pluripotent stem cells generated in xeno-free conditions
Dnyaneshwarrao DEVELOPMENT, OPTIMIZATION AND BIOLOGICAL EVALUATION OF AMNIOTIC MEMBRANE FOR REGENERATIVE THERAPY
Hill Development of a tissue engineering platform using bovine species as a model: placental scaffolds seeded with bovine adipose-derived cells
WO2025168108A1 (zh) Itm2a阳性骨骼/肌腱干细胞在治疗骨/肌腱损伤中的用途
CA3079500A1 (en) Pluripotent stem cells inducing osteochondral repair
Arrigoni ADIPOSE-DERIVED STEM CELLS (ASCS) FOR FUTURE CELLULAR THERAPIES IN MUSCLE-SKELETAL TISSUES REGENERATION

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150121

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160209

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20160315

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160531

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160630

R150 Certificate of patent or registration of utility model

Ref document number: 5964956

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250